Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Léo Mas

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Bulletin Du Cancer|August 7, 2022
[Advanced GIST: Which treatments in 2022?]Léo Mas, Jean-Baptiste Bachet
Current Opinion in Oncology|June 17, 2020
Adjuvant chemotherapy in pancreatic cancer: state of the art and future perspectivesLéo Mas, Lilian Schwarz, Jean-Baptiste Bachet
Bulletin Du Cancer|December 19, 2022
Léo Mas, Alexandre Perrier, Florence Coulet, et al.
Bulletin Du Cancer|June 18, 2021
[Neoadjuvant treatment for rectal cancer]Jean-Baptiste Bachet, Stéphane Benoist, Léo Mas, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 18, 2021
Chemotherapy of metastatic colon cancer in France: A population-based studyLéo Mas, Jean-Baptiste Bachet, Valérie Jooste, et al.
Bulletin Du Cancer|March 12, 2026
[Therapeutic de-escalation strategies in the use of anti-PD-1 and anti-PD-L1: Dose, frequency, and duration]Lila Philipps, Léo Mas, Thomas Samaille, et al.
Clinics and Research in Hepatology and Gastroenterology|July 23, 2024
Nationwide trends over 10 years in epidemiology and management of pancreatic ductal adenocarcinoma: A real-world study from the French administrative databaseLéo Mas, Christel Castelli, Amandine Coffy, et al.
Clinics and Research in Hepatology and Gastroenterology|June 25, 2026
€2.7 billion for the treatment of patients with pancreatic cancer: an overview and perspectives in FranceHonorat Agbéci, Christel Castelli, Amandine Coffy, et al.
International Journal of Molecular Sciences|July 2, 2021
Intraductal Papillary Mucinous Carcinoma Versus Conventional Pancreatic Ductal Adenocarcinoma: A Comprehensive Review of Clinical-Pathological Features, Outcomes, and Molecular InsightsLéo Mas, Renato M Lupinacci, Jérôme Cros, et al.
Bulletin Du Cancer|March 12, 2026
[Pancreatic acinar cell carcinoma: Clinical and theranostic characteristics]Andrea Marques, Léo Mas, Antoine Dardenne, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Bulletin Du Cancer|August 7, 2022
[Advanced GIST: Which treatments in 2022?]Léo Mas, Jean-Baptiste Bachet
Current Opinion in Oncology|June 17, 2020
Adjuvant chemotherapy in pancreatic cancer: state of the art and future perspectivesLéo Mas, Lilian Schwarz, Jean-Baptiste Bachet
Bulletin Du Cancer|December 19, 2022
Léo Mas, Alexandre Perrier, Florence Coulet, et al.
Bulletin Du Cancer|June 18, 2021
[Neoadjuvant treatment for rectal cancer]Jean-Baptiste Bachet, Stéphane Benoist, Léo Mas, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 18, 2021
Chemotherapy of metastatic colon cancer in France: A population-based studyLéo Mas, Jean-Baptiste Bachet, Valérie Jooste, et al.
Bulletin Du Cancer|March 12, 2026
[Therapeutic de-escalation strategies in the use of anti-PD-1 and anti-PD-L1: Dose, frequency, and duration]Lila Philipps, Léo Mas, Thomas Samaille, et al.
Clinics and Research in Hepatology and Gastroenterology|July 23, 2024
Nationwide trends over 10 years in epidemiology and management of pancreatic ductal adenocarcinoma: A real-world study from the French administrative databaseLéo Mas, Christel Castelli, Amandine Coffy, et al.
Clinics and Research in Hepatology and Gastroenterology|June 25, 2026
€2.7 billion for the treatment of patients with pancreatic cancer: an overview and perspectives in FranceHonorat Agbéci, Christel Castelli, Amandine Coffy, et al.
International Journal of Molecular Sciences|July 2, 2021
Intraductal Papillary Mucinous Carcinoma Versus Conventional Pancreatic Ductal Adenocarcinoma: A Comprehensive Review of Clinical-Pathological Features, Outcomes, and Molecular InsightsLéo Mas, Renato M Lupinacci, Jérôme Cros, et al.
Bulletin Du Cancer|March 12, 2026
[Pancreatic acinar cell carcinoma: Clinical and theranostic characteristics]Andrea Marques, Léo Mas, Antoine Dardenne, et al.
Pageof 2